C33H41N7O5S — CID 137356915
4-[(1S)-4-[[(6aS)-2-methoxy-11-oxo-6a,7,8,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]-1-aminobutyl]-1-methyl-N-[1-methyl-5-(thiomorpholine-4-carbonyl)pyrrol-3-yl]pyrrole-2-carboxamide (PubChem CID 137356915) has the molecular formula C33H41N7O5S and a molecular weight of 647.80 g/mol. Its IUPAC name is 4-[(1S)-4-[[(6aS)-2-methoxy-11-oxo-6a,7,8,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]-1-aminobutyl]-1-methyl-N-[1-methyl-5-(thiomorpholine-4-carbonyl)pyrrol-3-yl]pyrrole-2-carboxamide.
| Compound Name | 4-[(1S)-4-[[(6aS)-2-methoxy-11-oxo-6a,7,8,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]-1-aminobutyl]-1-methyl-N-[1-methyl-5-(thiomorpholine-4-carbonyl)pyrrol-3-yl]pyrrole-2-carboxamide |
|---|---|
| PubChem CID | 137356915 |
| Molecular Formula | C33H41N7O5S |
| Molecular Weight | 647.80 g/mol |
| Exact Mass | 647.29 |
| IUPAC Name | 4-[(1S)-4-[[(6aS)-2-methoxy-11-oxo-6a,7,8,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]-1-aminobutyl]-1-methyl-N-[1-methyl-5-(thiomorpholine-4-carbonyl)pyrrol-3-yl]pyrrole-2-carboxamide |
| SMILES | COc1cc2c(cc1OCCC[C@H](N)c1cc(C(=O)Nc3cc(C(=O)N4CCSCC4)n(C)c3)n(C)c1)N=C[C@@H]1CCCN1C2=O |
| InChI | InChI=1S/C33H41N7O5S/c1-37-19-21(14-27(37)31(41)36-22-15-28(38(2)20-22)33(43)39-9-12-46-13-10-39)25(34)7-5-11-45-30-17-26-24(16-29(30)44-3)32(42)40-8-4-6-23(40)18-35-26/h14-20,23,25H,4-13,34H2,1-3H3,(H,36,41)/t23-,25-/m0/s1 |
| InChIKey | NCHQICUDYLGYDP-ZCYQVOJMSA-N |
| XLogP | 3.99 |
| TPSA | 136.42 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 46 |
| Complexity | — |
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 647.80 |
| LogP ≤ 5 | 3.99 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 10 |
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|